Page 604 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 604
513.e6 Part V Red Blood Cells
242. Thunell S, Floderus Y, Henrichson A, et al: Alcoholic beverages in acute 255. Kumar A, Jazieh AR: Case report of sideroblastic anemia caused by
porphyria. J Stud Alcohol 53:272, 1992. ingestion of coins. Am J Hematol 66:126, 2001.
243. Haden HT: Pyridoxine-responsive sideroblastic anemia due to antitu- 256. Labbe RF, Rettmer RL: Zinc protoporphyrin: a product of iron-deficient
berculous drugs. Arch Intern Med 120:602, 1967. erythropoiesis. Semin Hematol 26:40, 1989.
244. Colucci G, Silzle T, Solenthaler M: Pyrazinamide-induced sideroblastic 257. Houston T, Moore MR, McColl KE, et al: Erythroid 5-aminolaevulinate
anemia. Am J Hematol 87:305, 2012. synthase activity during normal and iron deficient erythropoiesis. Br J
245. Firkin FC: Mitochondrial lesions in reversible erythropoietic depression Haematol 78:561, 1991.
due to chloramphenicol. J Clin Invest 51:2085, 1972. 258. O’Brien H, Amess JA, Mollin DL: Recurrent thrombocytopenia,
246. Kandola L, Swannell AJ, Hunter A: Acquired sideroblastic anaemia erythroid hypoplasia and sideroblastic anaemia associated with hypo-
associated with penicillamine therapy for rheumatoid arthritis. Ann thermia. Br J Haematol 51:451, 1982.
Rheum Dis 54:529, 1995. 259. Devgun MS, El-Nujumi AM, O’Dowd GJ, et al: Novel mutations
247. Willekens C, Dumezy F, Boyer T, et al: Linezolid induces ring sidero- in the Dubin-Johnson syndrome gene ABCC2/MRP2 and associated
blasts. Haematologica 98:138, 2013. biochemical changes. Ann Clin Biochem 49:609, 2012.
248. Brodsky RA, Hasegawa S, Fibach E, et al: Acquired sideroblastic 260. van de Steeg E, Stranecky V, Hartmannova H, et al: Complete
anaemia following progesterone therapy. Br J Haematol 87:859, 1994. OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome
249. Dameron C, Moore MR, Imray P, et al: Copper: environmental health by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest
criteria. Series no 200, Geneva, 1998, World Health Organization. 122:519, 2012.
250. Ashkenazi A, Levin S, Djaldetti M, et al: The syndrome of neonatal 261. McColl KE, Thompson GG, el Omar E, et al: Porphyrin metabolism
copper deficiency. Pediatrics 52:525, 1973. and haem biosynthesis in Gilbert’s syndrome. Gut 28:125, 1987.
251. Zidar BL, Shadduck RK, Zeigler Z, et al: Observations on the anemia 262. Moore MR: Health implications of the hemopoietic effects of lead. In
and neutropenia of human copper deficiency. Am J Hematol 3:177, Mahaffey KR, editor: Dietary and environmental lead: human health
1977. effects, Amsterdam, 1985, Elsevier.
252. Gregg XT, Reddy V, Prchal JT: Copper deficiency masquerading as 263. Oishi H, Nomiyama H, Nomiyama K, et al: Comparison between
myelodysplastic syndrome. Blood 100:1493, 2002. males and females with respect to the porphyrin metabolic disorders
253. Prodan CI, Holland NR, Wisdom PJ, et al: CNS demyelination associ- found in workers occupationally exposed to lead. Int Arch Occup
ated with copper deficiency and hyperzincemia. Neurology 59:1453, Environ Health 68:298, 1996.
2002. 264. Daniell WE, Stockbridge HL, Labbe RF, et al: Environmental chemical
254. Fiske DN, McCoy HE, 3rd, Kitchens CS: Zinc-induced sideroblastic exposures and disturbances of heme synthesis. Environ Health Perspect
anemia: report of a case, review of the literature, and description of the 105(Suppl 1):37, 1997.
hematologic syndrome. Am J Hematol 46:147, 1994.

